首页> 外文OA文献 >Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine
【2h】

Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine

机译:克罗地亚实验室止血测试的政策和实践:代表克罗地亚医学生物化学和实验室医学实验室混凝工作组进行的一项调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: The objective of this survey was to assess current policies and practice in haemostasis testing among both hospital and outpatient laboratories in Republic of Croatia.Materials and methods: A questionnaire with seventy questions divided into nine sections was created in May 2015. Participants were asked about their practice related to test request form, sample collection, prothrombin time (PT) and activated partial thromboplastin time assays, other individual haemostasis assays, point-of-care testing (POCT), reporting of coagulation tests results and quality assurance of procedures, the personnel and other laboratory resources, as well as on issues related to education and implementation of additional coagulation assays in their laboratory. The survey was administered and data were collected between June and September 2015. Results: A total survey response rate was 104/170 (61.2%). Most respondents were faced with incomplete information on prescribed therapy and diagnosis on the test request or inappropriate samples withdrawn on distant locations, but also do not have protocols for handling samples with high haematocrit values. Reporting of PT-INR and D-dimer results was different between laboratories. Although almost all laboratories developed a critical value reporting system, reporting a value to general practitioners is still a problem. Result on coagulation POCT testing showed that not all devices were supervised by laboratories, which is not in compliance with Croatian Chamber of Medical Biochemistry acts. Conclusion: Obtained results highlighted areas that need improvement and different practice patterns in particular field of haemostasis testing among laboratories. A harmonization of the overall process of haemostasis testing at national level should be considered and undertaken.
机译:简介:本次调查的目的是评估克罗地亚共和国医院和门诊实验室止血测试的现行政策和实践。材料与方法:2015年5月创建了问卷,该问卷包含70个问题,分为9个部分。关于其与测试申请表,样品收集,凝血酶原时间(PT)和活化的部分凝血活酶时间测定,其他个别止血测定,即时检验(POCT),凝血测试结果报告和程序质量保证相关的实践,人员和其他实验室资源,以及与他们实验室中的教育和其他凝血测定方法的实施和实施有关的问题。在2015年6月至2015年9月之间进行了调查并收集了数据。结果:调查总答复率为104/170(61.2%)。大多数受访者面临的处方治疗信息和测试要求的诊断信息不全,或者在遥远的地方撤回了不适当的样品,但也没有协议处理高血细胞比容值的样品。 PT-INR和D-二聚体结果的报告在实验室之间是不同的。尽管几乎所有实验室都开发了关键价值报告系统,但向全科医生报告价值仍然是一个问题。凝血POCT测试结果表明,并非所有设备均由实验室进行监督,这与克罗地亚医学生物化学商会的行为不符。结论:获得的结果强调了实验室之间止血测试特定领域中需要改进的领域和不同的实践模式。应考虑并在国家一级协调止血测试的整个过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号